IO INFORMATICS’ SENTIENT FEATURED IN CAMBRIDGE HEALTHTECH NEWLY RELEASED “BEST PRACTICES 2008” COMPENDIUM
BERKELEY, CA - CAMBRIDGE, MA October 7, 2008. Bio-IT World and Cambridge Healthtech Institute have released a compendium
of all those who participated in its annual industry competition, Best Practices 2008. Best Practices is designed to honor outstanding examples of practical relationships,
technologies, business strategies, and solutions that positively impact R&D; and drug discovery industries. Competitors were reviewed by a panel of 12 industry experts
who scored each on the significance of the entry, the level of innovation, the demonstration of ROI and the potential impact of the solution across the industry. The
compendium, which can be downloaded at www.bio-itworld.com/bestpractices, features listings and descriptions of
all submissions and highlights the winners in 7 sections: Basic Research & Development, Clinical research, Clinical Trials, Drug Discovery & Development, IT & Informatics,
Knowledge Management, Translational & Personalized Medicine. IO Informatics’ Sentient was awarded Honorable Mention for placing second in the Translational and
Personalized Medicine category behind Merck & Company.
“We are honored to have received Honorable Mention (2nd place) in the category for Translational & Personalized Medicine. This recognizes and rewards the spirit and
productivity of our collaboration with Best Practices submission partner, Cogenics (RTP, NC), as we worked together under NIST Advanced Technology Program (ATP) award
# 70NANB2H3009.” stated Bob Stanley, CEO/President of IO Informatics. “The Cambridge Healthtech Best Practices Awards are an excellent platform for companies to present
and showcase their latest practical advances and successes. It also serves to allow for the exchange of information and ideas within the scientific research community,
therefore fostering improvements based on open peer-review.”
Kevin Davies, Editor-in-Chief of Bio-IT World magazine said, “We would like to thank all those who participated in the 2008 Best Practices, and congratulate all the
winners. We had a record breaking number of entries this year in all the categories. A special congratulation goes to IO Informatics, not only for receiving Honorable Mention
for Translational & Personalized Medicine, but also for winning Best in Show at the BIO IT World Conference, for Life Science Informatics software. IO also received an award
for Best Scientific Poster. I guess you could call this a triple-play for the life science informatics company!”
“We would like to take this opportunity to invite researchers to submit entries for the 2009 Best Practices. Please go to:
www.bio-itworld.com/bestpractices".
IO Informatics attended last week’s Biomarker Discovery Summit 2008 in Philadelphia where they discussed the latest advances in life science informatics and demonstrated
the results of the feedback from their Semantic Applications in Life Sciences Working Group – which have been incorporated into the latest version of Sentient.
Background Information
About IO Informatics
IO Informatics is at the forefront of a global revolution in software methods for data integration. IO Informatics’ Sentient suite of software products enables biotechnology,
pharmaceutical, medical and other life science researchers to structure and define complex data relationships, view these relationships, query them, and capitalize on them —
all within a secure, compliant, auditable framework that helps organizations accumulate and leverage knowledge. Founded in 2003, IO Informatics is headquartered in Berkeley,
California (www.io-informatics.com).
About Cambridge Healthtech Institute
Founded in 1992, Cambridge Healthtech Institute (CHI) strives to develop quality information sources that provide valuable new insights and competing points of view while
offering balanced coverage of the latest developments in the life sciences industry. Basic research related to commercial implications is covered, with heavy emphasis placed
on end-user insights into new products and technology as well as coverage of the strategy behind the business. CHI is the preeminent life science network for leading researchers
and business experts from top pharmaceutical, biotech, and academic organizations. CHI’s integrated portfolio of products and services includes Cambridge Healthtech Institute
Conferences, the Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge
Healthtech’s Media Group, which includes numerous eNewsletters, Bio-IT World magazine, as well as Lead Generation Programs. For a comprehensive listing and detailed
information about CHI’s products and services, please visit www.chicorporate.com
back
|
